Clinical Trial Update: Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer [NA]

View source ↗

Summary

This clinical trial update reports that the study evaluating iBreast, a handheld device for detecting breast abnormalities during screening, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Screening | NA | Status: COMPLETED